Favezelimab/pembrolizumab
id:
favezelimab-pembrolizumab-312-551036
title:
Favezelimab/pembrolizumab
text:
Favezelimab/pembrolizumab is a fixed-dose combination of two monoclonal antibodies developed by Merck to treat various cancers.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Favezelimab/pembrolizumab
date created:
date modified:
2024-04-24T20:10:25Z
main entity:
{"identifier":"Q123530149","url":"https://www.wikidata.org/entity/Q123530149"}
image:
fields total:
13
integrity:
13